Harvard Pilgrim Health Care has reached agreements with Novartis and Eli Lilly to “pay for value” based on patient outcome for two of their most important medicines (Entresto and Trulicity). Read article here…..
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.